Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 18Gastrointestinal 16Head & Neck 8Genitourinary 8Dermatologic 8Thoracic 4Gynecologic 4Plasma cell 2Other neoplasm 2Other hematologic neoplasm 1Endocrine 1CNS 1

Conditions

Multiple Myeloma 3577Neoplasms, Plasma Cell 696Lymphoma 531Lymphoma, Non-Hodgkin 480Leukemia, Lymphocytic, Chronic, B-Cell 409Hodgkin Disease 405Recurrence 404Precursor Cell Lymphoblastic Leukemia-Lymphoma 375Leukemia 373Leukemia, Myeloid, Acute 363Myelodysplastic Syndromes 331Lymphoma, Large B-Cell, Diffuse 290Lymphoma, Mantle-Cell 288Lymphoma, Follicular 284Lymphoma, B-Cell, Marginal Zone 256Burkitt Lymphoma 249Immunoglobulin Light-chain Amyloidosis 227Myeloproliferative Disorders 226Lymphoma, Large-Cell, Immunoblastic 223Neoplasms 214Hematologic Neoplasms 200Primary Myelofibrosis 186Leukemia, Myeloid, Chronic-Phase 182Leukemia, Myeloid, Accelerated Phase 173Lymphoma, T-Cell, Cutaneous 170Waldenstrom Macroglobulinemia 164Blast Crisis 162Leukemia, Myelomonocytic, Chronic 158Mycosis Fungoides 147Sezary Syndrome 146

Interventions

daratumumab 1Patient Transfer 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Patient Satisfaction × Plasma cell × Clear all
NCT05971056 2024-10-03

Providing Cancer Care Closer to Home for Patients With Multiple Myeloma

Washington University School of Medicine

Phase NA Terminated
3 enrolled
Plasma cell

Financial Stress, Multiple Myeloma, Patient Satisfaction

NCT05284591 2024-10-01

MYLENE

iOMEDICO AG

Completed
96 enrolled
Plasma cell

Multiple Myeloma, Personal Satisfaction, Patient Satisfaction, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡